stella
beta
Phase 1b/2a Clinical Trial to Determine the Safety, Tolerability and Efficacy of TZ-161 in Spinal Cord Injury — Stella
Recruiting
Back to Acute Spinal Cord Injury (SCI) trials
Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations
(2 sites)
Spain
Hospital Universitario Reina Sofia, Córdoba
Hospital Universitario La Paz, Madrid
View full record on ClinicalTrials.gov